A Aforeworn
Forewarned is forearmed.
Home › Niches › Cosmetics & Personal-Care (MoCRA) › Change
Low urgency

FDA Clears First Over-the-Counter Continuous Glucose Monitor for Children

Detected July 6, 2026 · in Cosmetics & Personal-Care (MoCRA)

FDA clears first OTC continuous glucose monitor for children, but this is a medical device, not a cosmetic. No direct impact on MoCRA-regulated businesses.

Aforeworn detected this change in the Cosmetics & Personal-Care (MoCRA) space on July 6, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Low urgency. Cosmetics and personal care businesses under MoCRA should confirm how it applies to their specific situation before acting. There is a time constraint attached: N/A. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Cosmetics & Personal-Care (MoCRA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed. Regulated niches like Cosmetics & Personal-Care (MoCRA) move faster than most operators can track by hand, which is why Aforeworn watches the official sources for you and flags every material change the moment it appears.

What changed

FDA announcement about a medical device clearance; no changes to cosmetic regulations.

Who it affects

Cosmetics and personal care businesses under MoCRA

What you must do

No action needed for MoCRA compliance.

Deadline

N/A

Source: http://www.fda.gov/news-events/press-announcements/fda-clears-first-over-counter-continuous-glucose-monitor-children

Never miss a change like this again

Aforeworn watches Cosmetics & Personal-Care (MoCRA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.

Start your free trial

Related changes in Cosmetics & Personal-Care (MoCRA)